Peripheral Blood or Bone Marrow Stem Cells? Practical Considerations in Hematopoietic Stem Cell Transplantation
- 1 January 2019
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 33 (1) , 43-50
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Human Regulatory T Cells of G-CSF Mobilized Allogeneic Stem Cell Donors Qualify for Clinical ApplicationPLOS ONE, 2012
- Long-term outcomes after transplantation of HLA-identical related G-CSF–mobilized peripheral blood mononuclear cells versus bone marrowBlood, 2012
- Allogeneic transplantationCurrent Opinion in Oncology, 2012
- Regulatory T Cell Content in the Bone Marrow Graft Does Not Predict the Occurrence of Acute GVHDTransplantation and Cellular Therapy, 2011
- HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideTransplantation and Cellular Therapy, 2008
- Peripheral Blood Grafts from Unrelated Donors Are Associated with Increased Acute and Chronic Graft-versus-Host Disease without Improved SurvivalTransplantation and Cellular Therapy, 2007
- Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow TransplantationBlood, 2006
- Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantationLeukemia, 2003
- A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignanciesBlood, 2002
- A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignanciesBone Marrow Transplantation, 1998